Table 3 Prostate cancer history of the study sample (N = 133)
|  | Total (N = 133) |
|---|---|
Years diagnosed with PC | |
 Mean ± SD | 6.45 ± 4.35 |
Metastatic disease (%) | 93 (69.92Â %) |
 Visceral metastases (of those with metastatic disease) (%) | 24 (25.81 %) |
Number of bone metastases | |
 None (%) | 73 (54.89 %) |
 1 (%) | 17 (12.78 %) |
 2 (%) | 12 (9.02 %) |
 3 (%) | 11 (8.27 %) |
 4+ (%) | 20 (15.04 %) |
Skeletal-related events | |
 Bone pain (%) | 34 (25.56 %) |
 Bone fracture (%) | 3 (2.26 %) |
 Spinal cord compression (%) | 10 (7.52 %) |
 Bone surgery (%) | 3 (2.26 %) |
 Radiation to the bone (%) | 12 (9.02 %) |
 Other (%) | 1 (0.75 %) |
 None (%) | 93 (69.92 %) |
Symptomatic status | |
 Symptomatic (%) | 27 (20.30 %) |
 Asymptomatic (%) | 106 (79.70 %) |
ECOG performance status | |
 Grade 0 (%) | 85 (63.91 %) |
 Grade 1 (%) | 42 (31.58 %) |
 Grade 2 (%) | 5 (3.76 %) |
 Grade 3 (%) | 1 (0.75 %) |